Retraction: Chamaejasmin B decreases malignant characteristics of mouse melanoma B16F0 and B16F10 cells

1

The study on Chamaejasmin B's effects on melanoma cell lines has been retracted due to integrity concerns regarding the figures.
2

Ethical issues arose as tumor sizes exceeded animal welfare limits and did not comply with ethics approval parameters.
3

An investigation confirmed that the experiments violated the approval from the Shihezi University Animal Care and Use Committee.
4

The retraction was approved by the Chief Editors of Frontiers in Oncology and the Chief Executive Editor of Frontiers.
5

The authors of the study have agreed to the retraction following the findings of the investigation.

Frontiers In Oncology

1